PRTN3 and anti-neutrophil cytoplasmic antibody-associated vasculitis: While the ANCA specificity has mostly not regarded predictive to patient survival [7, 16, 23], a recent, large cluster analysis in AAV patients found a 5.9-fold mortality in renal patients without PR3-ANCA [31].